Taiwan FDA registration d77ec6c5f11dd26cc0d0c2931f67daf1
“Bard” Glidepath Long-Term Hemodialysis Catheter
TW: “巴德”葛萊帕斯長期性血液透析導管
Taiwan·Risk Class 3·MD·BARD ACCESS SYSTEMS, INC.·Registered Jul 25, 2020 – Jul 25, 2025ExpiredRegistration details
- Analysis ID
- d77ec6c5f11dd26cc0d0c2931f67daf1
- License Form
- Ministry of Health Medical Device Import No. 033814
- Customs Code
- DHA05603381403
Company information
- Manufacturer
- BARD ACCESS SYSTEMS, INC.
- Manufacturer Country
- United States
- Authorized Representative
- BARD PACIFIC HEALTH CARE CO., LTD.
Product details
- Intended Use
- For details, it is Chinese approved copy of the imitation order
- Product Type (Level 1)
- H Gastroenterology-urology devices
- Product Type (Level 2)
- H5540 Blood access devices and accessories
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jul 25, 2020
- Expiry Date
- Jul 25, 2025
About this record
Access comprehensive regulatory information for “Bard” Glidepath Long-Term Hemodialysis Catheter in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number d77ec6c5f11dd26cc0d0c2931f67daf1 and manufactured by BARD ACCESS SYSTEMS, INC.. The authorized representative in Taiwan is BARD PACIFIC HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices